(Q51388002)
Statements
Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes (English)
N P E Kadoglou
H Tsanikidis
I Vitta